Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

AxdAdB3-F/RGD

Recombinant Adenovirus Expressing Mutant E1A

Catalog number RDB03012
Resource name AxdAdB3-F/RGD
Clone info. Recombinant Adenovirus Expressing Mutant E1A.
Vector backbone pL-dAdB3 (Adenovirus)
Growth remarks 5 percent FCS is fine.
Gene/insert name AdV_5 E1A cDNA
Depositor|Developer Hamada, Hirofumi |
Other clones in our bank

External Database
AdV_5 E1A

            Reference sequence
              

            Distribution information

            Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
            Terms and conditions set forth by the DEPOSITOR The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(Clin. Cancer Res., 13, 3043-3050 (2007).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
            Ordering Please visit Information of Request for Distribution.[link] 
            Order form 
            [Credit Card Payment]  [Bank Transfer Payment]
            提供案内 (日本国内) [open/close]

            提供条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Clin. Cancer Res., 13, 3043-3050 (2007).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
            提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
            提供依頼書 [Word]
            遺伝子組換え生物の受入れ確認書 [Word]
            備考 【追加提供依頼書】受入れ確認書(書式J)
            作出したウイルスは大臣確認実験となる。
            組換え体提供にかかる書式が必要です。

            Catalog # Resource name Availability Shipping form Fee (non-profit org.)
            RDB03012 AxdAdB3-F/RGD Under QC test. Please contact us. Virus, lysate of infected cell culture

            check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
            Ordering Information [in Japanese] [in English]

            References and tips

            Electronic file

            Remarks, protocol and/or map (gif) RDB03012.gif

            Original reference

            original Wakayama M., E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers. Clin. Cancer Res., 13, 3043-3050 (2007). PMID 17505007.

            Further references such as user reports and related articles (go to bottom)

            Featured content


            Sequence information

            check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.


            References

            Original, user report and related articles

            original Wakayama M., E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers. Clin. Cancer Res., 13, 3043-3050 (2007). PMID 17505007.
            user report Shen, Y.H., Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice. PLoS One. 11 (1): e0147173 (2016). PMID 26799485.
            user report Wang, H., Enhanced Antitumor Efficacy of Integrin-targeted Oncolytic Adenovirus AxdAdB3-F/RGD on Bladder Cancer. Urology, pii: S0090-4295(13) 01369-1 (2013). PMID 24315309.

            2022.02.09

            GNP_filter3_RDBDEP_html_220112.pl